Source:http://www.reactome.org/biopax/48887BiochemicalReaction1815
Predicate | Object |
---|---|
rdf:type | |
biopax3:comment |
Activation of the PI3K signaling pathway has been demonstrated for a number of FGFR1 fusion proteins and inhibitors of this pathway impair the proliferative and survival function of the fusions (Guasch, 2001; Demiroglu, 2001; Chen, 2004; Lelievre, 2008). FGFR1 fusions lack the FRS2-binding site of the full length protein, so the mechanism of PI3K recruitment is unclear. Unlike BCR-FGFR1, which has been shown to recruit GRB2 through the BCR Y177 site, GRB2 did not co-precipitate with the ZMYM2-FGFR1 fusion (Roumianetsev, 2004). In the case of FOP-FGFR1, Y730 has been shown to be required for the recruitment of the p85 subunit of PI3K; however, CEP110-FGFR1, which contains Y730 in the context of the same pYXXM motif, was not shown to recruit p85 at the centrosome (Guasch, 2001).,
Authored: Rothfels, K, 2012-02-09,
Edited: Rothfels, K, 2012-05-16,
Reviewed: Ezzat, S, 2012-05-15
|
biopax3:xref |
http://identifiers.org/pubmed/11689702,
http://identifiers.org/pubmed/11739186,
http://identifiers.org/pubmed/15050920,
http://identifiers.org/pubmed/15448205,
http://identifiers.org/pubmed/18412956,
urn:biopax:UnificationXref:REACTOME DATABASE ID_1839078,
urn:biopax:UnificationXref:REACTOME_REACT_120762_1
|
biopax3:dataSource | |
biopax3:displayName |
FGFR1 fusion proteins recruit PIK3R1
|
biopax3:left | |
biopax3:right |